A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group

Author:

Marvaso Giulia1ORCID,Mastroleo Federico12ORCID,Corrao Giulia1ORCID,Zaffaroni Mattia1ORCID,Vincini Maria Giulia1ORCID,Borghetti Paolo3ORCID,Cuccia Francesco4ORCID,Federico Manuela5ORCID,Montesi Giampaolo6,Pontoriero Antonio78ORCID,Franceschini Davide9,Franzese Ciro910ORCID,Scorsetti Marta910,Jereczek-Fossa Barbara Alicja111

Affiliation:

1. Division of Radiation Oncology, European Institute of Oncology IRCCS (IEO), 20141 Milan, Italy

2. Department of Translational Medicine, University of Piemonte Orientale (UPO), 13100 Novara, Italy

3. Radiation Oncology Department, ASST Spedali Civili and University of Brescia, 25123 Brescia, Italy

4. Radiotherapy Unit, ARNAS Civico Hospital, 90127 Palermo, Italy

5. Casa di cura Macchiarella, U.O. Radioterapia Oncologica, 90127 Palermo, Italy

6. Radiation Oncology Department, ‘S.M. Della Misericordia’ Hospital, AULSS 5 Veneto, 45100 Rovigo, Italy

7. Department of Biomedical, Dental and Morphological and Functional Imaging Sciences, University of Messina, 98122 Messina, Italy

8. Radiation Oncology Unit, A.O.U. Policlinico “G. Martino” Messina, 98124 Messina, Italy

9. Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Milan, Italy

10. Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy

11. Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy

Abstract

The term “oligometastasis” represents a relatively novel idea, which denotes a condition characterized by cancer dissemination with a limited number of lesions (usually fewer than five). The aim of the present study is to report a bibliometric analysis of the oligometastatic disease/state, incorporating all relevant studies on the topic for more than 20 years. The research strategy included at least one the terms “Oligmetastases”, “Oligometastasis”, “Oligometastatic”, “Oligoprogression, “Oligoprogressive”, “Oligorecurrent”, or “Oligorecurrency” in the title, abstract, and/or keywords. All English-language documents from 1 January 1995 (the year of the earliest available document in Scopus) to 31 December 2022 were considered for the analysis. R code (R version 4.2.0) with R Studio (version 2022.12.0-353) and the Bibliometrix package (version 4.0.1) were used for the analysis. A total of 3304 documents, mainly articles (n = 2083, 63.0%) and reviews (n = 813, 24.6%), were collected from 1995 to 2022. The average annual growth rate of literature on the topic was 26.7%. Overall 15,176 authors published on the topic, with an average of eight authors/publication. From 1995, 69 countries contributed to the literature, with the USA and Italy being the top contributors. Among all keywords used by authors, the top three were oligometastases (19%), SBRT (18%), and radiation therapy (8%). Themes regarding “locoregional treatment”, “organ motion”, and “immunotherapy” were the most recent trend topics, mainly developed from 2019 to 2022, while “high-dose chemotherapy”, “whole-brain radiotherapy”, and “metastatic breast cancer” saw their main development during 2009–2018. Our study shows the exceptionally flourishing scientific production on the oligometastatic state, summarizing the most influential studies and highlighting the future developments and interests. This analysis will serve as a benchmark to identify this area for the attention of researchers worldwide and contribute to the increasing scientific work.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3